Karen Katen retired as Vice Chairman of Pfizer, Inc. and as President of Pfizer Human Health in 2007. Pfizer Human Health is the company’s principal operating group, responsible for the discovery, development, manufacture, distribution and commercialization of prescription medicines, as well as for providing a broad array of innovative human-health services. Ms. Katen’s career at Pfizer, Inc. spanned 33 years.
Ms. Katen joined EWHV in October 2007 as a Senior Advisor based in the New York office. She is a director on the boards of the Harris Corporation, The Home Depot, Air Liquide, and the Takeda Global Advisory Board. She also serves on the Catalyst Board, the RAND Corporation’s Health Board of Advisors, ARMGO Pharmaceutical’s Board and the Economic Club of New York Board of Trustees. She has also served as chairman of the Pfizer Foundation. Ms. Katen holds a B.A. and M.B.A. from the University of Chicago, where she now serves as a University Trustee and a council member of its Booth School of Business.
Ms. Katen’s achievements have received wide recognition. In 2005, Karen was named among the top ten in Fortune Magazine’s ranking of “50 Most Powerful Women in Business,” a list that included her for eight consecutive years. For her commitment to community and improving public health, she received eleven distinct “Woman of the Year” or similar awards from civic groups, national associations and universities.
|
